The Changing Treatment Landscape for MDR/XDR-TB — Can Current Clinical Trials Revolutionise and Inform a Brave New World?

International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2019.02.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Methodological Considerations in Clinical Trials for New MDR-TB Treatment Regimens

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2016English

Ireland’s Potential MDR-TB and XDR-TB Problem

Irish Journal of Medical Science
Medicine
2010English

Predictive Factors for Unfavourable Treatment in MDR-TB and XDR-TB Patients in Rio De Janeiro State, Brazil, 2000-2016

PLoS ONE
Multidisciplinary
2019English

Effectiveness and Safety of Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- And XDR-TB

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Challenging MDR-TB Clinical Problems- The Case for a New Global TB Consilium Supporting the Compassionate Use of New Anti-Tb Drugs

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Participating in Trials Can Inform Better Clinical Practice

British Journal of Dermatology
DermatologyMedicine
2017English

Improper Anti-Tb Treatment- Almost Certain Recipe for MDR-Tb

Journal of Evolution of Medical and Dental Sciences
2018English

Brave New World

Journal of Catholic Education
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy